Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I

Authors

John F. DiPersio, Washington University School of Medicine in St. LouisFollow
et alFollow

Journal

Haematologica

Publication Date

2015

Volume

100

Issue

4

Inclusive Pages

479-488

Document Type

Open Access Publication

DOI

10.3324/haematol.2014.115840

Rights and Permissions

John F. DiPersio, et al. (2015) Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I. Haematologica 100(4):479-488. doi:10.3324/haematol.2014.115840. Obtained from the Haematologica Journal website http://www.haematologica.org

Recommended Citation

DiPersio, John F. and et al, "Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I." Haematologica. 100, 4. 479-488. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4229